Deleterious clinical effects of transfusion-associated immunomodulation: fact or fiction?
Blood
.
2001 Mar 1;97(5):1180-95.
doi: 10.1182/blood.v97.5.1180.
Authors
E C Vamvakas
1
,
M A Blajchman
Affiliation
1
Department of Pathology, New York University Medical Center, New York, NY 10016, USA. stephen.vamvakas@med.nyu.edu
PMID:
11222359
DOI:
10.1182/blood.v97.5.1180
No abstract available
Publication types
Review
MeSH terms
Clinical Trials as Topic
Humans
Immunosuppression Therapy / adverse effects*
Infections / etiology
Infections / immunology
Leukocytes
Neoplasms / etiology
Neoplasms / immunology
Transfusion Reaction*